Author

C. Kortsik

Observed names: C KORTSIK, C Kortsik, C S Kortsik, C St Kortsik, C. S. Kortsik, C. St. F. Kortsik, C.St.F. Kortsik, Cornelius Kortsik, Kortsik, C., Kortsik, Cornelius

Observed institutions: King Edward Medical University, University of Freiburg, Merck KGaA, Darmstadt (Germany), Eli Lilly (United States), German Cancer Research Center, Johannes Gutenberg University Mainz, Heidelberg University, University Medical Center Freiburg, University Hospital Heidelberg, Princess Margaret Cancer Centre, Deutsche Klinik für Diagnostik, University Medical Center of the Johannes Gutenberg University Mainz, Chung Shan Medical University Hospital, St. Vincentius-Kliniken, Essen University Hospital, Asklepios Fachkliniken München-Gauting, The Christie Hospital, Lungenklinik Hemer, University Hospital Magdeburg, Asklepios Klinikum Harburg, Mayo Hospital, St. James's Hospital, University Medical Centre Mannheim, Asklepios, Medizinische Fakultät Mannheim, University of Duisburg-Essen, Medical University of Vienna, Uzhhorod National University, Dnipro State Medical University

OpenAlex ID: A5108398953

T Cells and Cytokines in Bronchoalveolar Lavage Fluid after Segmental Allergen Provocation in Atopic Asthma

1995 · J C Virchow, C Walker, et al. · American Journal of Respiratory and Critical Care Medicine · 222

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

2011 · Kenneth J O'Byrne, Ulrich Gatzemeier, et al. · The Lancet Oncology · 205

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

2005 · C. Manegold, J. Symanowski, et al. · Annals of Oncology · 160

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

2005 · Giorgio V. Scagliotti, Cornelius Kortsik, et al. · Clinical Cancer Research · 139

PDF

The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial

2010 · Martin Sebastian, Martin Reck, et al. · Journal of Thoracic Oncology · 113

Highly Focused T Cell Responses in Latent Human Pulmonary Mycobacterium tuberculosis Infection

2005 · Glenn Tully, Cornelius Kortsik, et al. · The Journal of Immunology · 102

Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study

2009 · K. J. O'Byrne, I. Bondarenko, et al. · Journal of Clinical Oncology · 92

Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study Group

2004 · E. Laack, N. Dickgreber, et al. · Journal of Clinical Oncology · 90

PDF

Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study

2018 · Marlene Hechtner, Martin Eichler, et al. · Journal of Thoracic Oncology · 87

PDF

Sonographische Milzgrößenbestimmung: Normalmaße beim milzgesunden Erwachsenen

2008 · K. Frank, P. Linhart, et al. · Ultraschall in der Medizin - European Journal of Ultrasound · 63

Severe Barium Sulfate Aspirationinto the Lung: Clinical Presentation, Prognosis and Therapy

1999 · Ingo Tamm, Cornelius Kortsik · Respiration · 58

Comparison of the Sensitivity of Sputum and Brush Cytology in the Diagnosis of Lung Carcinomas

1997 · Andreas Sing, Nikolaus Freudenberg, et al. · Acta Cytologica · 54

Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis

2007 · F F Weichold, S Mueller, et al. · Genes and Immunity · 46

Psychological distress in lung cancer survivors at least 1 year after diagnosis—Results of a German multicenter cross‐sectional study

2018 · Martin Eichler, Marlene Hechtner, et al. · Psycho-Oncology · 40

Longitudinal analysis of Mycobacterium tuberculosis 19‐kDa antigen‐specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross‐reactivity to a peptide from HIVenv gp120

2003 · Hanni Höhn, Cornelius Kortsik, et al. · European Journal of Immunology · 33

PDF

Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany

2020 · Humayra Rashid, Martin Eichler, et al. · Supportive Care in Cancer · 31

PDF

MHC class II Tetramer Guided Detection of Mycobacterium tuberculosis‐specific CD4+ T Cells in Peripheral Blood from Patients with Pulmonary Tuberculosis

2007 · H. Höhn, C. Kortsik, et al. · Scandinavian Journal of Immunology · 26

PDF

Pleural Effusion due to Histoplasma capsulatum and Idiopathic CD4 Lymphocytopenia

2003 · C. Kortsik, A. Elmer, et al. · Respiration · 26

Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer

2014 · D.F. Heigener, K.M. Deppermann, et al. · Lung Cancer · 25

Expression of KIT (CD117) in Biphasic Pulmonary Blastoma. Novel Data on Histogenesis

2003 · T. Hansen, F. Bittinger, et al. · Lung · 25

Comparison of sputum‐ECP levels in bronchial asthma and chronic bronchitis

1993 · J. C. Virchow, C. Kroegel, et al. · Allergy · 23

[The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals].

1991 · E Holm, U Staedt, et al. · PubMed · 23

Randomized phase II trial of two dosing schedules of BI 2536, a novel Plk-1 inhibitor, in patients with relapsed advanced or metastatic non-small-cell lung cancer (NSCLC)

2008 · J. Von Pawel, M. Reck, et al. · Journal of Clinical Oncology · 22

Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28– T cell subpopulation

2003 · H HÖHN, M JÜLCH, et al. · Clinical & Experimental Immunology · 22

PDF

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

2003 · G.V. Scagliotti, C. Kortsik, et al. · Lung Cancer · 21

Works count: 102

Citation count: 2,047

H-index: 22

I10-index: 38